Search

everythinglearnresearchcommunity

for

Search:↓

Many Egyptian women who were hospitalized for COVID-19 experienced significant hair loss afterwards.

Treating post-COVID hair loss leads to full recovery, while not treating it often results in ongoing symptoms.

A woman lost all her hair in one day, was diagnosed with a rare type of hair loss, and regrew it in 12 weeks with treatment.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Dengue fever can cause hair loss that may lead to serious psychological issues like Body Dysmorphic Disorder in young women.

Telogen effluvium is a common, reversible hair loss condition treatable with patient education and sometimes Minoxidil.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Hair loss can occur in the area where hair was taken for a transplant.

RV3466F lotion significantly reduces hair loss and improves acute telogen effluvium.

A woman had temporary hair loss after a facelift, which improved on its own within a year.

Individualized homeopathic treatment led to complete hair regrowth in a patient with stress-induced hair loss.

A female runner's hair loss was caused by stress from surgery and recovery, but her hair returned to normal in 5 months.

The study identified five types of long COVID symptoms and suggests tailored management strategies for each.

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

A COVID-19 infected patient with chronic kidney disease experienced worsened kidney function, hair loss, and unexpected wart clearance.

A woman's hair loss after COVID-19 was likely due to a mix of pressure-induced alopecia and acute telogen effluvium.

Some people in Saudi Arabia experienced hair loss after the COVID-19 vaccine, more often in women and those without prior hair loss.

The authors suggest that a new type of hair loss exists, which is different from alopecia areata.

Finasteride slightly better long-term, minoxidil faster initial results, but stopping minoxidil may cause hair loss.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

The study concluded that low iron and vitamin D levels in women might play a role in chronic hair loss, despite no significant difference between those with and without hair loss.

Post-COVID-19 patients are at risk for hair loss.

More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.

The food supplement with L-cystine, Serenoa repens extract, and biotin safely reduced hair loss and improved hair growth in men and women.

COVID-19 can cause different types of hair loss, which may last up to 100 days, and treatments are still being explored.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

COVID-19 can cause hair loss starting as early as 18 days after infection.